Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase

Scandinavian Journal of Immunology

Volumn 60, Issue 4, 2004, Pages 392-402

  El Ridi, R ^a   Montash, M ^a   Tallima, H ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PEPTIDE DMAP A; PEPTIDE DMAP B; PEPTIDE DMAP B1; PEPTIDE DMAP C; PEPTIDE DMAP D; PEPTIDE DMAP E; SCHISTOSOMA VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SPECIFICITY; ENZYME ANALYSIS; FERTILITY; GENE CONSTRUCT; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SEQUENCE HOMOLOGY; WORM;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES;

EID: 4944258749     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01497.x     Document Type: Article

References (30)

1. Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Tropica 2000;77:41-51.
2. Bergquist NR, Al-Sherbiny M, Barakat R, Olds R. Blueprint for schistosomiasis vaccine development. Acta Tropica 2002;82:183-92 [review].
3. Brindley PJ. Drug resistance to schistosomicides and other anthelmintics of medical significance. Acta Tropica 1994;56:213-31.
4. Bennett JL, Day T, Liang FT, Ismail M, Farghaly A. The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel. Exp Parasitol 1997;87:260-7 [review].
5. El Ridi R, El Garem AA. Is an anti-Schistosoma haematobium vaccine necessary? Int J Parasitol 1999;29:651-3.
6. Coulson PS. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 1997;39:271-336.
7. Butterworth AE. Human immunity to schistosomes: Some questions. Parasitol Today 1994;10:378-80.
8. Dunne D, Mountford A. Resistance to infection in humans and animal models. In: Mahmoud, AAF, ed. Schistosomiasis. Imperial College Press, London 2001, 133-212.
9. McManus DP. The search for a vaccine against schistosomiasis - a difficult path but an achievable goal. Immunol Rev 1999;171:149-61.
10. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Tropica 2003;88:117-30.
11. El Ridi R. Toward a complete immunity-inducing vaccine for schistosomiasis. J Parasitol 2002;88:1049-50.
12. Dessein AJ, Begley M, Demeure C et al. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol 1988;140:2727-36.
13. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 1989;170:2065-80.
14. El Ridi R, Farouk F, Sherif M et al. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both Schistosomiasis mansoni and haematobium. J Infect Dis 1998;177:1364-72.
15. El Ridi R, Shoemaker CB, Farouk F, El Sherif NH, Afifi A. Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy. Infect Immun 2001;69:237-44.
16. El Ridi R, Mahrous A, Afifi A, Montash M, Velek J, Jezek J. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis. Scand J Immunol 2001;54:477-85.
17. El Ridi R, Mohamed SH, Tallima H. Incubation of Schistosoma mansoni lung-stage schistosomula in corn oil exposes their surface antigenic specificities. J Parasitol 2003;89:1064-7.
18. Tallima H, Montash M, Veprek P, Velek J, Jezek J, El Ridi R. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Vaccine 2003;21:3290-300.
19. Veprek P, Jezek J, Velek J, Montash M, Tallima H, El Ridi R. Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL/6 mice. J Pept Sci 2004;10:350-62.
20. Tam JP. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 1988;85:5409-13.
21. Tam JP. Recent advances in multiple antigen peptides. J Immunol Methods 1996;196:17-32 [review].
22. Smithers SR, Terry RJ. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 1965;55:695-700.
23. Cheever AW. Relative resistance of the eggs of human schistosomes to digestion in potassium hydroxide. Bull World Health Organ 1970;43:601-3.
24. He R-Q, Yang M-D, Zheng X, Zhou J-X. Isolation and some properties of glycated D-glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle. Biochem J 1995;309:133-9.
25. Engelhard VH. Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 1994;12:181-207.
26. Pessi A, Valmori D, Migliorini P et al. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide. Eur J Biochem 1991;21:2273-6.
27. Marguerite M, Bossus M, Mazingue C et al. Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide. Mol Immunol 1992;29:793-800.
28. Reynolds SR, Dahl CE, Harn DA. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1994;152:193-200.
29. Argiro L, Henri S, Dessein H, Kouriba B, Dessein AJ, Bourgois A. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum. Vaccine 2000;18:2033-8.
30. Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem 2001;276:2480-6.